QSS
PACB icon

Quantitative Systematic Strategies’s Pacific Biosciences PACB Stock Holding History

Quantitative Systematic Strategies’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-16,226
Closed -$567K – 264
2021
Q2 		$567K Sell
16,226
-16,677
-51% -$485K 0.2% 202
2021
Q1 		$1.1M Sell
32,903
-4,326
-12% -$151K 0.17% 204
2020
Q4 		$966K Sell
37,229
-46,957
-56% -$798K 0.14% 246
2020
Q3 		$831K Buy
84,186
+65,116
+341% +$375K 0.14% 210
2020
Q2 		$66K Buy
+19,070
New +$64.9K 0.01% 561
2016
Q4 		– Sell
-11,973
Closed -$106K – 400
2016
Q3 		$106K Buy
+11,973
New +$100K 0.04% 358
2016
Q2 		– Sell
-17,242
Closed -$150K – 496
2016
Q1 		$150K Sell
17,242
-59,806
-78% -$588K 0.06% 357
2015
Q4 		$1.01M Buy
+77,048
New +$691K 0.27% 38

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Quantitative Systematic Strategies's PACB Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of Pacific Biosciences (PACB) in Q3 2021, closing a stake of 16,226 shares — an estimated $567K sold.

Quantitative Systematic Strategies first reported a position in PACB in Q4 2015 and held it in 8 quarters. The position peaked at $1.1M in Q1 2021. 246 funds tracked by Wall St. Rank hold PACB as of Q3 2021.

  • Quantitative Systematic Strategies reported no remaining Pacific Biosciences position as of Q3 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 16,226 Pacific Biosciences shares in Q3 2021, an estimated $567K.
  • Quantitative Systematic Strategies first reported a position in Pacific Biosciences in Q4 2015 and held it in 8 quarters.
  • Quantitative Systematic Strategies's Pacific Biosciences position peaked at $1.1M in Q1 2021.
  • 246 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.